Case Study / 15 Jun 2011


Novartis commissioned Trucost to measure its supply chain environmental risk.

Novartis has a diverse healthcare portfolio, including innovative pharmaceuticals, eye care products, generics, consumer health products, and vaccines and diagnostic tools.

Greenhouse gas emissions and other environmental impacts embedded in the supply chains of major organisations generally far exceed the environmental impacts for which they are directly responsible. Understanding supply chain emissions, environmental costs, and the resulting supplier-buyer interaction often offers a significant opportunity to reduce emissions, improve efficiencies, and reduce cost. Novartis commissioned Trucost to provide a comprehensive assessment of the carbon, waste and water supply chain footprint and identified areas of greatest impact.

“By measuring the environmental footprint and cost of our supply chain we are now able to better understand our impacts and embed sustainability in our strategic decision making. This provides us with the opportunity to improve efficiency and reduce environmental impact from the most intensive suppliers as well as helping to mitigate future reputational risk.”

Events Webinar: Climate Risk: What are the implications of TCFD for Companies? 6 June 2019

Join us for a complimentary webinar as we discuss why and how companies are being asked to disclose on the financial implications of climate-related risks and opportunities.

Find out more
Publication / 02 May 2019 The Socioeconomic and Environmental Impact of Large-Scale Diamond Mining

Trucost, part of S&P Global were commissioned to undertake a world-first comprehensive analysis of...

Read publication